ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center

By: Newsfile

Houston, Texas--(Newsfile Corp. - September 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) announces a Statewide Educational Seminar Series on the TCUP Expansion, as Texas healthcare is experiencing a historic breakthrough with the approval of House Bill 46 (HB 46). Signed into law on June 21, 2025, by Governor Greg Abbott, the expansion of the Texas Compassionate Use Program (TCUP) will cover chronic pain, PTSD, and degenerative neurological conditions, among others, and will directly benefit more than one million Texans, including 300,000 veterans. The law also updates permissible cannabinoid concentrations, signaling a decisive step toward integrating cannabis-based therapies into clinical practice.

The Statewide Educational Seminar Series will take place in key cities: UTHealth Houston — November 15, 2025; Austin, TX — December 6, 2025; Dallas, TX — January 17, 2026; El Paso, TX — February 21, 2026. Sessions will address patient registration, prescriber responsibilities, regulatory and liability considerations, reimbursement pathways, and the latest evidence in cannabinoid science.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/10188/268301_flyer_seminario_tcup_1_550.jpg

Figure 1

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10188/268301_flyer_seminario_tcup_1.jpg

CBIH is also entering a stage of accelerated growth driven by key factors such as cannabis tax reductions in California, the expansion of legislation in Texas, regulatory updates in Delaware, and progress toward banking reform. These developments directly strengthen the company's revenue outlook and reinforce its market position. Jennifer Salguero Ph.D. in Sciences noted that the cannabis industry is moving toward unprecedented financial stability, creating a unique opportunity for CBIH to increase its revenue streams, expand its educational/research programs, and deliver sustained value to CBIH revenue-generating centers.

"This is a transformative milestone for medical cannabis in Texas," said Rosangel Andrades, M.D., CBIH Director of R&D. "Participants will not only stay informed-they will help shape patient care, professional practice, and the scientific agenda ahead."

Cannabis Bioscience International Holdings is a global leader in cannabis research and education, with a track record of government-authorized training partnership in Puerto Rico and six years of accredited programs across six universities in Colombia. CBIH's library includes 150+ instructional videos and 250+ eBooks and audiobooks in seven languages, equipping professionals to integrate cannabis therapies safely and scientifically.

For the agenda, speaker bios and abstracts — Julian González, M.D. (Clinical Medicine), and Brian Cuban, Esq. (Legal Perspectives / Law & Professional Well-Being) — as well as ongoing updates, please visit the event webpage: www.vitabiotechresearch.com. This is a watershed moment for healthcare in Texas-one that reflects a shared commitment to science, safety, and patient dignity, and that sets the stage for evidence-based practice, responsible policy, and improved patient outcomes in the years ahead.

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.

For more information contact us at:

(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268301

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.